Back to News
May 21, 2026 4:10 AM

Liminatus Pharma Is Trending Overnight — Here's Why LIMN Stock Surged Over 79% In After-Hours Session

Liminatus Pharma Inc. (NASDAQ:LIMN) shares are trending on Friday.

LIMN shares surged 79.34% to $0.34 after the bell on Thursday.

The stock of the biopharmaceutical company had experienced an intraday drop of 1.16%, closing at $0.19, according to Benzinga Pro data.

Liminatus announced a definitive merger agreement with Delaware-based limited liability company InnocsAI LLC on Thursday. According to the company announcement, InnocsAI members will receive 1.6 billion shares at $0.20 per share, plus contingent value rights representing 20% of net proceeds from future asset exits.

What You Should Know

Notably, Liminatus’s CEO Chris Kim controls Valetudo Therapeutics LLC, a member of InnocsAI.

Liminatus Pharma has over 44.8 million shares outstanding.

The deal brings a clinical-stage oncology portfolio, including IBC101, a CD19xCD22 bivalent CAR-T candidate ...